Enalapril for Preventing Cardiotoxicity After High-Dose Anthracycline Therapy in Breast Cancer and Lymphoma Patients.
作者信息
Cardinale Daniela, Marenzi Giancarlo
机构信息
Cardioncology Unit, European Institute of Oncology, Milan, Italy.
Centro Cardiologico Monzino, IRCCS, Milan, Italy.
出版信息
JACC CardioOncol. 2025 Apr;7(3):317-318. doi: 10.1016/j.jaccao.2025.01.014. Epub 2025 Mar 18.
Abstract
摘要
相似文献
1
Enalapril for Preventing Cardiotoxicity After High-Dose Anthracycline Therapy in Breast Cancer and Lymphoma Patients.依那普利预防乳腺癌和淋巴瘤患者大剂量蒽环类药物治疗后的心脏毒性
JACC CardioOncol. 2025 Apr;7(3):317-318. doi: 10.1016/j.jaccao.2025.01.014. Epub 2025 Mar 18.
2
Preventing cardiotoxicity in patients with breast cancer and lymphoma: protocol for a multicentre randomised controlled trial (PROACT).预防乳腺癌和淋巴瘤患者心脏毒性：一项多中心随机对照试验（PROACT）方案。
BMJ Open. 2022 Dec 30;12(12):e066252. doi: 10.1136/bmjopen-2022-066252.
3
Preventing Cardiac Damage in Patients Treated for Breast Cancer and Lymphoma: The PROACT Clinical Trial.预防乳腺癌和淋巴瘤患者的心脏损伤：PROACT临床试验
JACC CardioOncol. 2024 Aug 27;6(5):684-696. doi: 10.1016/j.jaccao.2024.07.010. eCollection 2024 Oct.
4
Reply: Enalapril for Preventing Cardiotoxicity After High-Dose Anthracycline Therapy in Breast Cancer and Lymphoma Patients.回复：依那普利预防乳腺癌和淋巴瘤患者大剂量蒽环类药物治疗后的心脏毒性。
JACC CardioOncol. 2025 Apr;7(3):319. doi: 10.1016/j.jaccao.2025.02.002. Epub 2025 Mar 18.
5
Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.儿童癌症治疗期间及治疗后用于治疗蒽环类药物引起的有症状和无症状心脏毒性的医学干预措施。
Cochrane Database Syst Rev. 2011 Sep 7(9):CD008011. doi: 10.1002/14651858.CD008011.pub2.
6
Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.儿童癌症治疗期间及治疗后用于治疗蒽环类药物引起的有症状和无症状心脏毒性的医学干预措施。
Cochrane Database Syst Rev. 2016 Aug 23;2016(8):CD008011. doi: 10.1002/14651858.CD008011.pub3.
7
Role of ACE inhibitors in anthracycline-induced cardiotoxicity: A randomized, double-blind, placebo-controlled trial.ACE 抑制剂在蒽环类抗生素诱导的心脏毒性中的作用：一项随机、双盲、安慰剂对照试验。
Pediatr Blood Cancer. 2018 Nov;65(11):e27308. doi: 10.1002/pbc.27308. Epub 2018 Jul 15.
8
Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: a prospective, parallel-group, randomized, controlled study with 36-month follow-up.多柔比星治疗淋巴瘤患者中美托洛尔和依那普利的心脏保护作用：一项前瞻性、平行组、随机、对照研究，随访 36 个月。
Am J Hematol. 2010 Nov;85(11):894-6. doi: 10.1002/ajh.21840.
9
Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial.蒽环类药物诱导的心脏毒性：一项比较依那普利两种预防策略的多中心随机试验：国际心脏肿瘤学会一项试验。
Eur J Cancer. 2018 May;94:126-137. doi: 10.1016/j.ejca.2018.02.005. Epub 2018 Mar 20.
10
Anthracycline cardiotoxicity after breast cancer treatment.乳腺癌治疗后的蒽环类药物心脏毒性。
Oncology (Williston Park). 2009 Mar;23(3):227-34.
本文引用的文献
1
Preventing Cardiac Damage in Patients Treated for Breast Cancer and Lymphoma: The PROACT Clinical Trial.预防乳腺癌和淋巴瘤患者的心脏损伤：PROACT临床试验
JACC CardioOncol. 2024 Aug 27;6(5):684-696. doi: 10.1016/j.jaccao.2024.07.010. eCollection 2024 Oct.
2
Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial.蒽环类药物诱导的心脏毒性：一项比较依那普利两种预防策略的多中心随机试验：国际心脏肿瘤学会一项试验。
Eur J Cancer. 2018 May;94:126-137. doi: 10.1016/j.ejca.2018.02.005. Epub 2018 Mar 20.
3
Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies).依那普利和卡维地洛预防恶性血液病患者化疗引起的左心室收缩功能障碍：OVERCOME 试验（依那普利和卡维地洛预防接受强化化疗治疗恶性血液病患者左心室功能障碍）。
J Am Coll Cardiol. 2013 Jun 11;61(23):2355-62. doi: 10.1016/j.jacc.2013.02.072. Epub 2013 Apr 10.
4
Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition.通过血管紧张素转换酶抑制预防高危患者高剂量化疗引起的心脏毒性。
Circulation. 2006 Dec 5;114(23):2474-81. doi: 10.1161/CIRCULATIONAHA.106.635144. Epub 2006 Nov 13.
5
Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy.高剂量化疗后早期肌钙蛋白I释放所预测的左心室功能障碍
J Am Coll Cardiol. 2000 Aug;36(2):517-22. doi: 10.1016/s0735-1097(00)00748-8.
Zotero 插件